All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Posttreatment plasma transforming growth factor beta 1 level predicts for late morbidity in parients with advanced head and neck cancer

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F05%3AA0900HLJ" target="_blank" >RIV/61988987:17110/05:A0900HLJ - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Posttreatment plasma transforming growth factor beta 1 level predicts for late morbidity in parients with advanced head and neck cancer

  • Original language description

    Methods and materials Between 2001-2002, 36 patients with advanced inoperable squamous head and neck cancer treated with radiotherapy with or without simultaneous chemotherapy were evaluated for their plasma TGF-b1 levels prior to the treatment, in the middle of the radiotherapy course and at the end of the treatment. The patients were assessed for treatment response and late morbidity. Results There were 29 eligible patients (pts), the rest being lost of follow-up. Of these 29 pts, 18 achieved completeresponse, 8 partial response and three pts progressed primarily. After a median follow-up of 16 months (range 3-28), we recorded 16 cases of grade > 1 late morbidity. We found that posttreatment elevated plasma TGF-b1 level predicts late morbidity grade>1 (p=0,05 see Graph 1) rather than pretreatment level (p=0,062). Conclusion Posttreatment plasma TGF-beta 1 level can predict late morbidity grade >1 in advanced head and neck cancer treated with radio(chemo)therapy.

  • Czech name

    Poléčebná hodnota TGF-beta1 predikuje vyšší postradiační morbiditu u pacientů s pokročilými ORL malignitami

  • Czech description

    Publikace hodnotí prediktivní význam TGF-beta1 u pacientů ozařovaných pro pokročilé nádory hlavy a krku. Výsledkem publikace je, že vysoká poléčebná hodnota TGF-beta1 predikuje vyšší pozdní postradiační morbiditu.

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2005

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    NEOPLASMA

  • ISSN

    0028-2685

  • e-ISSN

  • Volume of the periodical

    52

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    SK - SLOVAKIA

  • Number of pages

    5

  • Pages from-to

  • UT code for WoS article

    000232222100007

  • EID of the result in the Scopus database